For example, the company's work is designed to facilitate the predicting of coronavirus mutations and enable drugs and vaccines to be more quickly adapted to mutations. International partners and customers include the University of Harvard, Google, Merck, Henkel and SignalChem.
What makes this so special is that Innophore compares a different part of the data pool than its competitors involved in digital drug development, which primarily analyse the structure and sequence of proteins. In principle, the company in Graz investigates the empty space for the docking of the medicines on the protein. At the end of last year two patents for this were issued in the United States and Europe.
Continue reading and learn more about life sciences research in Austria!